Pediatric and adolescent HIV disease

Annals of Allergy, Asthma and Immunology

Volumn 98, Issue 5, 2007, Pages 405-413

  Secord, Elizabeth ^a   Cotronei Cascardo, Cristina ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR PLUS LAMIVUDINE; ATAZANAVIR; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; RITONAVIR;

ADOLESCENT DISEASE; CHILDHOOD DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RATE; INTERNET; MEDLINE; PRACTICE GUIDELINE; PREGNANT WOMAN; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REVIEW; VIRUS TRANSMISSION;

EID: 34248594989     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60753-3     Document Type: Review

References (43)

1. Winston DJ. Pneumocystis carinii pneumonia. Compr Ther. 1981;7:41-48.
2. Durack D. Opportunistic infections and Kaposi's sarcoma in young homosexual men. N Engl J Med. 1981;305:1465-1467.
3. Centers for Disease Control (CDC). Update on acquired immune deficiency syndrome (AIDS) - United States. MMWR Morb Mortal Wkly Rep. 1982;31:507-514.
4. Rubinstein A. Immunodeficiency syndrome in infants. Am J Dis Child. 1983;137:825-827.
5. Gallo RC, Sarin PS, Gelmann EP, et al. Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS). Science. 1983;220:865-867.
6. Barre-Sinoussi F, Chermann JC, Rey F, et al. Isolation of a T-lymphotrophic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science. 1983;220:868-871.
7. Centers for Disease Control. From the Centers for Disease Control: interpretation and use of the Western blot assay for serodiagnosis of human immunodeficiency virus type 1 infections. JAMA. 1989;262:3395-3397.
8. Kempf DJ, Norbeck DW, Codacovi L, et al. Structure-based, C2 symmetric inhibitors of HIV protease. J Med Chem. 1990;33:2687-2689.
9. Meek TD, Dreyer GB. HIV-1 protease as a potential target for anti-AIDS therapy. Ann N Y Acad Sci. 1990;616:41-53.
10. Pearson ML. Rational targets for design and synthesis of anti-HIV agents. Ann N Y Acad Sci. 1990;616:86-89.
11. Centers for Disease Control and Prevention. CDC:HIV/AIDS surveillance report: HIV infection and AIDS in the United States. MMWR Morb Mortal Wkly Rep. 2003.
12. American Academy of Pediatrics. HIV. In: Red Book. 27th ed. Elk Grove Village, Ill: American Academy of Pediatrics; 2006:378-401.
13. Working Group on Antiretroviral Agents and Medical Management of HIV-infected Children. Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection. Bethesda, MD: National Institutes of Health; October 26, 2006.
14. Sperling RS, Shapiro DE, Coombs RW, et al; Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. N Engl J Med. 1996;335:1621-1629.
15. Mofenson LM, Lambert JS, Stiehm ER, et al; Pediatric AIDS Clinical Trials Group Study 185 Team. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. N Engl J Med. 1999;341:385-393.
16. Garcia PM, Kalish LA, Pitt J, et al; Women and Infants Transmission Study Group. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. N Engl J Med. 1999;341:394-402.
17. Weisser M, Battegay M. Does pregnancy influence the course of HIV infection? evidence from two large Swiss cohort studies. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;17:404-410.
18. Peters V, Liu KL, Dominguez K, et al. Missed opportunities for perinatal HIV prevention among HIV-exposed infants born 1996-2000, pediatric spectrum of HIV disease cohort. Pediatrics. 2003;111:1186-1191.
19. Centers for Disease Control and Prevention. Rapid HIV-1 antibody testing during labor and delivery for women of unknown HIV status: a practical guide and model protocol. MMWR Morb Mortal Wkly Rep. 2004.
20. Landesman SH, Kalish LA, Burns DN, et al. Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child: the Women and Infants Transmission Study. N Engl J Med. 1996;334:1617-1623.
21. American Academy of Pediatrics. Human milk, breastfeeding, and transmission of human immunodeficiency virus in the United States. Pediatrics. 1995;96:977-979.
22. Dunn DT, Newell ML, Ades AE, Peckham CS. Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet. 1992;340:585-588.
23. Becquart P, Hocini H, Levy M, Sepou A, Kazatchkine MD, Belec L. Secretory anti-human immunodeficiency virus (HIV) antibodies in colostrum and breast milk are not a major determinant of the protection of early postnatal transmission of HIV. J Infect Dis. 2000;181:532-539.
24. Becquart P, Gresenguet G, Hocini H, Kazatchkine MD, Belec L. Secretory leukocyte protease inhibitor in colostrum and breast milk is not a major determinant of the protection of early postnatal transmission of HIV. AIDS. 1999;13:2599-2602.
25. Cooper DA, Gold J, Maclean P, et al. Acute AIDS retrovirus infection: definition of a clinical illness associated with seroconversion. Lancet. 1985;1:537-540.
26. Centers for Disease Control and Prevention. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. MMWR Morb Mortal Wkly Rep. 2005.
27. Cote JK, Godin G. Efficacy of interventions in improving adherence to antiretroviral therapy. Int J STD AIDS. 2005;16:335-343.
28. Naar-King S, Arfken C, Frey M, Harris M, Secord E, Ellis D. Psychosocial factors and treatment adherence in paediatric HIV/AIDS. AIDS Care. 2006;18:621-628.
29. Ellis DA, Naar-King S, Cunningham PB, Secord E. Use of multisystemic therapy to improve antiretroviral adherence and health outcomes in HIV-infected pediatric patients: evaluation of a pilot program. AIDS Patient Care STDS. 2006;20:112-121.
30. Dybul MFA, Bartlett JG, Kaplan JE, Pau AK; Panel on Clinical Practices for Treatment of HIV. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Ann Intern Med. 2002;137:381-433.
31. Brun-Vezinet FCD, Khaled MA, Calvez V, et al. Clinically validated genotype analysis: guiding principles and statistical concerns. Antivir Ther. 2004;9:465-478.
32. Liuzzi G. Genotypic resistance tests for the management of the patient failing highly active antiretroviral therapy: the resistance pattern in different biological compartments. Scand J Infect Dis. 2003;35:90-93.
33. Kuritzkes D. Preventing and managing antiretroviral drug resistance. AIDS Patient Care STDS. 2004;18:259-273.
34. Holodniy M. Phenotypic and genotypic testing in clinical practice. AIDS Patient Care STDS. 1998;12:527-531.
35. Lauria FN Angeletti C. Cost-effectiveness analysis of using antiretroviral drug resistance testing. Scand J Infect Dis Suppl. 2003;35(suppl 106):54-57.
36. Heilek-Snyder GBP. Role of HIV phenotypic assays in the management of HIV infection. Am Clin Lab. 2002;21:40-43.
37. Andreoni M. Phenotypic resistance testing. Scand J Infect Dis Suppl. 2003;35(suppl 106):35-36.
38. Smith DK, Grohskopf LA, Black RJ, et al. Antiretroviral post-exposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services. MMWR Recomm Rep. 2005;54:1-20.
39. Kaplan EH, Heimer R. HIV incidence among needle exchange participants: estimates from syringe tracking and testing data. J Acquir Immune Defic Syndr. 1994;7:182-189.
40. Myers SS, Heimer R, Liu D, Henrard D. HIV DNA and antibodies in syringes from injecting drug users: a comparison of detection techniques. AIDS. 1993;7:925-931.
41. Donegan E, Stuart M, Niland JC, et al. Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations. Ann Intern Med. 1990;113:733-739.
42. Varghese B, Maher JE, Peterman TA, Branson BM, Steketee RW. Reducing the risk of sexual HIV transmission: quantifying the per-act risk for HIV on the basis of choice of partner, sex act, and condom use. Sex Transm Dis. 2002;29:38-43.
43. European Study Group on Heterosexual Transmission of HIV. Comparison of female to male and male to female transmission of HIV in 563 stable couples. BMJ. 1992;304:809-813.